Skip to main content
TMS Co., Ltd logo

TMS Co., Ltd — Investor Relations & Filings

Ticker · 4891 ISIN · JP3544960002 T Manufacturing
Open in API
Filings indexed 40 across all filing types
Latest filing 2026-05-12 Share Issue/Capital Cha…
Country JP Japan
Listing T 4891

About TMS Co., Ltd

https://www.tms-japan.co.jp/en.html

TMS Co., Ltd. is a clinical-stage company focused on the research, development, manufacture, and sale of drug products, quasi-drugs, and medical devices. Founded by scientists from the Tokyo University of Agriculture and Technology, the company aims to discover and develop transformative medicines for diseases with high unmet medical needs. Its research centers on a group of fungus-derived small molecule compounds known as SMTPs, which exhibit a novel dual mode of action. The company's objective is to create revolutionary drugs for conditions that currently lack effective treatments.

Recent filings

Filing Released Lang Actions
ストック・オプションとしての新株予約権の発行内容確定に関するお知らせ
Share Issue/Capital Change Classification · 90% confidence The document is a Japanese regulatory announcement by a listed company (TMS, code 4891) detailing the finalized terms for issuing new stock acquisition rights (stock options), including number of rights, payment amount, target shares, and allocation. This is a capital change event announcing the issuance of new shares (via stock acquisition rights under a stock option plan). Therefore it fits the Share Issue/Capital Change category (SHA).
2026-05-12 Japanese
第10回新株予約権（行使価額修正条項付）の月間行使状況に関するお知らせ
Regulatory Filings
2026-05-01 Japanese
ストック・オプションとしての新株予約権の発行に関するお知らせ
Regulatory Filings
2026-04-15 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is titled '確認書' (Confirmation Letter) and explicitly references '金融商品取引法第24条の４の２第１項' (Article 24-4-2, Paragraph 1 of the Financial Instruments and Exchange Act). It is a formal certification by the CEO and CFO confirming the accuracy of the contents of the Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations, even if they reference a report, should be classified as Regulatory Filings (RNS). FY 2025
2026-03-30 Japanese
有価証券報告書－第22期(2025/03/01－2025/12/31)
Annual Report Classification · 100% confidence The document is a 'Yuka Shoken Hokokusho' (Annual Securities Report) filed with the Kanto Local Finance Bureau in Japan. It contains comprehensive financial statements, management discussion, and corporate information for the fiscal year ending December 31, 2025. This is the Japanese equivalent of a 10-K filing. FY 2025
2026-03-30 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under Article 24-5-2 of the Financial Instruments and Exchange Act of Japan, which accompanies a semi-annual report (第２四半期報告書). Since this document is a formal regulatory filing required to accompany the interim report to confirm the accuracy of the financial statements, and it does not contain the full financial report itself, it falls under the category of Regulatory Filings.
2025-10-15 Japanese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.